Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Clin Genet ; 83(5): 422-31, 2013 May.
Article in English | MEDLINE | ID: mdl-22909335

ABSTRACT

Valosin containing protein (VCP) disease associated with inclusion body myopathy, Paget disease of the bone and frontotemporal dementia is a progressive autosomal dominant disorder caused by mutations in Valosin containing protein gene. To establish genotype-phenotype correlations we analyzed clinical and biochemical markers from a database of 190 members in 27 families harboring 10 missense mutations. Individuals were grouped into three categories: symptomatic, presymptomatic carriers and noncarriers. The symptomatic families were further divided into ten groups based on their VCP mutations. There was marked intra and inter-familial variation; and significant genotype-phenotype correlations were difficult to establish because of small numbers. Nevertheless when comparing the two most common mutations, R155C mutation was found to be more severe, with an earlier onset of myopathy and Paget (p = 0.03). Survival analysis of all subjects revealed an average life span after diagnosis of myopathy and Paget of 18 and 19 years respectively, and after dementia only 6 years. R155C had a reduced survival compared to the R155H mutation (p = 0.03).We identified amyotrophic lateral sclerosis (ALS) was diagnosed in 13 individuals (8.9%) and Parkinson's disease in five individuals (3%); however, there was no genotypic correlation. This study represents the largest dataset of patients with VCP disease and expands our understanding of the natural history and provides genotype-phenotype correlations in this unique disease.


Subject(s)
Adenosine Triphosphatases/genetics , Cell Cycle Proteins/genetics , Frontotemporal Dementia/complications , Genetic Association Studies , Myositis, Inclusion Body/complications , Myositis, Inclusion Body/genetics , Osteitis Deformans/complications , Adenosine Triphosphatases/metabolism , Adult , Aged , Biopsy , Cell Cycle Proteins/metabolism , Electromyography , Exons , Female , Frontotemporal Dementia/diagnosis , Frontotemporal Dementia/mortality , Genotype , Humans , Male , Middle Aged , Muscle, Skeletal/pathology , Mutation , Myositis, Inclusion Body/diagnosis , Myositis, Inclusion Body/mortality , Neural Conduction , Osteitis Deformans/diagnosis , Osteitis Deformans/mortality , Valosin Containing Protein , Young Adult
2.
Clin Lymphoma ; 1(4): 298-302, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11707845

ABSTRACT

DAB(389)IL-2 (denileukin diftitox, ONTAK) is a cytokine-targeted fusion protein that delivers the catalytic domain of diphtheria toxin to lymphoma cells expressing the interleukin-2 receptor (IL-2R). In phase I and phase III studies of DAB(389)IL-2 in patients with cutaneous T-cell lymphoma (CTCL), non-Hodgkin's lymphoma, and Hodgkin's disease in which premedications were limited to diphenhydramine and acetaminophen, acute infusion-related hypersensitivity reactions occurred in 70% of patients and vascular leak syndrome (VLS) in 27%, resulting in discontinuation of therapy in 29% of patients. There was no correlation between the dose or half-life of DAB(389)IL-2 and the occurrence of hypersensitivity events or VLS. To explore whether steroid premedication would improve the tolerability of DAB(389)IL-2, we treated 15 patients with CTCL with either dexamethasone or prednisone prior to each dose of DAB(389)IL-2. The incidence of acute infusion events was significantly decreased, with only three patients experiencing acute infusion events (one grade 4) and only two patients developing clinically apparent VLS. Grade 3 skin rash occurred in two patients and moderately severe asthenia in nine patients. A significantly improved response rate of 60% was noted with the use of steroid premedication compared to prior studies in which steroids were prohibited. We conclude that steroid premedication significantly improves the tolerability of DAB(389)IL-2 without compromising the clinical response.


Subject(s)
Diphtheria Toxin/adverse effects , Drug Hypersensitivity/prevention & control , Glucocorticoids/therapeutic use , Immunosuppressive Agents/adverse effects , Immunotoxins/adverse effects , Interleukin-2/adverse effects , Lymphoma, T-Cell, Cutaneous/drug therapy , Recombinant Fusion Proteins/adverse effects , Skin Neoplasms/drug therapy , Adult , Aged , Aged, 80 and over , Combined Modality Therapy , Dexamethasone/therapeutic use , Diphtheria Toxin/therapeutic use , Drug Hypersensitivity/etiology , Female , Humans , Immunosuppressive Agents/therapeutic use , Immunotoxins/therapeutic use , Interleukin-2/therapeutic use , Lymphocytes/immunology , Lymphoma, T-Cell, Cutaneous/metabolism , Male , Middle Aged , Neoplasm Staging , Prednisone/therapeutic use , Premedication , Recombinant Fusion Proteins/therapeutic use , Skin Neoplasms/metabolism , Syndrome , Treatment Outcome
3.
Arch Ophthalmol ; 119(11): 1637-42, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11709014

ABSTRACT

OBJECTIVE: To describe the epithelial healing rates observed in freshly cultured rabbit corneas chemically burned with high-concentration hydrochloric acid (HCl) and sodium hydroxide (NaOH) and subsequently treated with phototherapeutic keratectomy (PTK). METHODS: We obtained 126 fresh corneoscleral rims from cadaveric New Zealand white rabbits. Each cornea was exposed to 4-mm cellulose sponges soaked in a solution of topical 0.9% isotonic sodium chloride solution, 2M HCl, or 0.5M NaOH. A transepithelial PTK (6-mm zone; 100-microm ablation depth) was then performed using the excimer laser (150-mJ/cm(2) energy pulse; 20 nanosecond duration; and 10-Hz frequency). Corneas were placed in tissue culture, and 1 cornea from each group was taken out of culture each day after treatment. Re-epithelialization was monitored by means of fluorescein staining, slitlamp photography, and histopathological analysis. RESULTS: Corneas treated with HCl and NaOH exhibited immediate epithelial defects that slowly healed over time. In PTK-treated corneas, the re-epithelialization rate was accelerated compared with that of controls (P =.003 for the HCl group, and P<.001 for the NaOH group). The new epithelial layers were smoother in PTK-treated corneas, as confirmed by results of histopathological analysis. CONCLUSION: Corneal damage caused by HCl and NaOH may be modulated in vitro by PTK in this rabbit model. CLINICAL RELEVANCE: After corneal chemical damage, 193-nm excimer laser PTK accelerates epithelial wound healing.


Subject(s)
Burns, Chemical/metabolism , Epithelial Cells/physiology , Epithelium, Corneal/physiology , Eye Burns/chemically induced , Photorefractive Keratectomy , Wound Healing , Animals , Burns, Chemical/pathology , Cornea/surgery , Corneal Injuries , Fluorophotometry , Hydrochloric Acid , Lasers, Excimer , Organ Culture Techniques , Rabbits , Sodium Hydroxide
4.
Lasers Surg Med ; 29(3): 288-92, 2001.
Article in English | MEDLINE | ID: mdl-11573233

ABSTRACT

BACKGROUND AND OBJECTIVE: Most of the in vitro work to characterize the effects of clinical laser surgery on corneal tissues has concentrated on the effects on stromal keratocytes and endothelium with little attention being paid to corneal epithelium. Our purpose is to describe the epithelial healing rates observed in freshly cultured rabbit corneas treated with phototherapeutic keratectomy (PTK). STUDY DESIGN/MATERIALS AND METHODS: Corneas were placed in a simple organ culture system, with media change every 2 days. A clinical excimer laser was used to perform a 6 mm diameter, 100 microm depth transepithelial PTK on 24 cultured rabbit corneas, 1 day after culture initiation. For each post-treatment day, one experimental and one control cornea were removed from culture and stained with fluorescein, photographed, and fixed for histology. Epithelial defect area was measured with digital imaging software and analyzed statistically to assess the re-epithelialization rate. RESULTS: Control corneas, maintained in culture for 1-4 days, had no epithelial defects. Those corneas treated with PTK exhibited an immediate epithelial defect that slowly healed over 3 days. This was confirmed on histopathological analysis. A significant linear trend in re-epithelialization across the time points studied was found (F = 80.48, P = 0.0029). The slope of the linear regression model showed an estimate rate of re-epithelialization of -6.70 over the 3 days. CONCLUSION: We have described the development of a simple, whole organ, rabbit cornea culture model for re-epithelialization after PTK. Our rates of epithelial healing resemble those found in the literature in live rabbit models. Therefore, this model may possibly be used to monitor epithelial wound healing in different corneal diseases or injuries.


Subject(s)
Epithelium, Corneal/radiation effects , Models, Biological , Photorefractive Keratectomy/adverse effects , Radiation Injuries, Experimental/etiology , Radiation Injuries, Experimental/pathology , Wound Healing/radiation effects , Animals , Disease Models, Animal , Epithelium, Corneal/injuries , Epithelium, Corneal/pathology , Fluorescein , Lasers, Excimer , Organ Culture Techniques , Rabbits , Time Factors
5.
Lung Cancer ; 28(1): 1-10, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10704703

ABSTRACT

Small cell carcinoma of the lung (SCLC) occurs most frequently in heavy smokers, yet exhibits a lesser predominance among men than other smoking-associated lung cancers. Incidence rates have increased more rapidly in women than men and at a faster rate among women than other cell types. To investigate the importance of smoking and other risk factors, a case-control study of SCLC in women was conducted. A total of 98 women with primary SCLC and 204 healthy controls, identified by random-digit dialing and frequency matched for age, completed telephone interviews. Data collected include demographics, medical history, family cancer history, residence history, and lifetime smoking habits. Odds ratios (ORs) and 95% confidence intervals (95% CI) were calculated using logistic regression analysis. Risk for small cell carcinoma in women is strongly associated with current use of cigarettes. Ninety-seven of 98 cases had smoked cigarettes; 79% of cases were current smokers and 20% were former smokers at the time of diagnosis compared to 13% current and 34% former smokers among controls. The ORs associated with smoking are 108.7 (95% CI 14.8-801) for ever-use of cigarettes, 278.9 (95% CI 37.0-2102) for current smoking, and 31.5 (95% CI 4. 1-241) for former smoking. Risk increases steeply with pack-years of smoking and decreases with duration of smoking cessation. After adjusting for age, education, and lifetime smoking history, medical history of physician-diagnosed respiratory disease including chronic bronchitis, emphysema, pneumonia, tuberculosis, asthma, and hay fever is not associated with a significant increase in lung cancer risk. Employment in blue collar, service, or other high risk occupations is associated with a two to three-fold non-significant increase in risk for small cell carcinoma after adjusting for smoking.


Subject(s)
Carcinoma, Small Cell/etiology , Lung Neoplasms/etiology , Occupational Exposure/adverse effects , Respiratory Tract Diseases/complications , Smoking/adverse effects , California/epidemiology , Carcinoma, Small Cell/epidemiology , Carcinoma, Small Cell/pathology , Female , Humans , Incidence , Lung Neoplasms/epidemiology , Lung Neoplasms/pathology , Middle Aged , Retrospective Studies , Risk Factors , Surveys and Questionnaires
6.
J Thorac Cardiovasc Surg ; 118(6): 1101-9, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10595985

ABSTRACT

OBJECTIVE: Bilateral staple lung volume reduction surgery (LVRS) immediately improves pulmonary function and dyspnea symptoms in patients with advanced heterogeneous emphysema to a greater degree than do unilateral procedures. However, the long-term outcome after these surgical procedures needs to be critically evaluated. We compare 2-year survival of patients who underwent unilateral versus bilateral video-assisted LVRS in a large cohort treated by a single surgical group. METHODS: The cases of all 260 patients who underwent video-assisted thoracoscopic stapled LVRS from April 1994 to March 1996 were analyzed to compare results after unilateral versus bilateral procedures. Overall survival was calculated by Kaplan-Meier methods; Cox proportional hazard methods were used to adjust for patient heterogeneity and baseline differences between groups. RESULTS: Overall survival at 2 years was 86.4% (95% CI 80. 9%-91.8%) after bilateral LVRS versus 72.6% (95% CI 64.2%-81.2%) after unilateral LVRS (P =.001 for overall survival comparison). Improved survival after bilateral LVRS was seen among high- and low-risk subgroups as well. Average follow-up time was 28.5 months (range, 6 days to 46.6 months) for the bilateral LVRS group and 29.3 months (range, 6 days to 45.0 months) for the unilateral LVRS patients. CONCLUSIONS: Comparison of unilateral versus bilateral thoracoscopic LVRS procedures for the treatment of emphysema reveals that bilateral LVRS by video-assisted thoracoscopy resulted in better overall survival at 2-year follow-up than did unilateral LVRS. This survival study, together with other studies demonstrating improved lung function after bilateral LVRS, suggests that bilateral surgery appears to be the procedure of choice for patients undergoing LVRS for most eligible patients with severe heterogeneous emphysema.


Subject(s)
Pneumonectomy/methods , Pulmonary Emphysema/surgery , Age Factors , Aged , Cohort Studies , Confidence Intervals , Dyspnea/physiopathology , Dyspnea/surgery , Female , Follow-Up Studies , Forced Expiratory Volume/physiology , Humans , Longitudinal Studies , Lung/physiopathology , Male , Oxygen/blood , Proportional Hazards Models , Residual Volume/physiology , Risk Factors , Surgical Stapling , Survival Rate , Thoracic Surgery, Video-Assisted , Total Lung Capacity/physiology , Treatment Outcome , Vital Capacity/physiology
7.
Curr Opin Pulm Med ; 4(4): 198-204, 1998 Jul.
Article in English | MEDLINE | ID: mdl-10813232

ABSTRACT

Lung cancer incidence is now decreasing in US men. Although rates continue to increase in women, the rate of increase is declining. Most lung cancer in men and women is attributable to cigarette smoking. Histologic patterns are consistent with smoking trends for gender, race, and age. Trends in adenocarcinoma may be related to an increase in exposure to tobacco-specific nitrosamines from low-tar cigarettes. Other risk factors, including exposure to residential radon, occupational exposures, diet, and family history, have been shown to increase risk of lung cancer independent of cigarette smoking. Recent research in molecular epidemiology has greatly increased our understanding of the mechanism of lung carcinogenesis and the interactions between exposure to lung carcinogens (smoking, occupational exposures, radon), diet, and heritable variations in susceptibility.


Subject(s)
Adenocarcinoma/epidemiology , Carcinoma, Large Cell/epidemiology , Carcinoma, Non-Small-Cell Lung/epidemiology , Carcinoma, Small Cell/epidemiology , Carcinoma, Squamous Cell/epidemiology , Lung Neoplasms/epidemiology , Adenocarcinoma/diagnosis , Adult , Age Distribution , Aged , Carcinoma, Large Cell/diagnosis , Carcinoma, Non-Small-Cell Lung/diagnosis , Carcinoma, Small Cell/diagnosis , Carcinoma, Squamous Cell/diagnosis , Female , Humans , Incidence , Lung Neoplasms/diagnosis , Male , Middle Aged , Risk Factors , Sex Distribution , Survival Rate , United States/epidemiology
8.
J Thorac Cardiovasc Surg ; 114(6): 957-64; discussion 964-7, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9434691

ABSTRACT

OBJECTIVE: Our intent was to refine the patient selection criteria for lung volume reduction surgery because various centers have different criteria and not all patients benefit from the procedure. METHODS: Patient information, x-ray results, arterial blood gases, and plethysmographic pulmonary function tests in 154 consecutive patients who underwent bilateral thoracoscopic staple lung volume reduction surgery were compared with clinical outcome (change in forced expiratory volume in 1 second and dyspnea scale) with t tests and analysis of variance. RESULTS: Three hundred thirty-three of 487 (69%) patients evaluated for lung volume reduction surgery were rejected for lack of heterogeneous emphysema (n = 212), medical contraindications (n = 88), hypercapnia (n = 20), uncontrolled anxiety or depression (n = 10), or pulmonary hypertension (n = 1). Two patients died during the evaluation process. When tested by analysis of variance, there was no difference in clinical outcome associated with preoperative forced expiratory volume in 1 second, residual volume, total lung capacity, single-breath diffusing, and arterial oxygen or carbon dioxide tension. All patients selected for the operation had a heterogeneous pattern of emphysema. The upper lobe heterogeneous pattern of emphysema on chest computed tomography and lung perfusion scan was strongly associated with improved outcome with a mean (95% confidence interval) improvement in forced expiratory volume in 1 second of 73.2% (63.3 to 83.1) for the upper lobe compared with a mean (95% confidence interval) improvement of 37.9% (22.9 to 53.0) for the lower lobe or diffuse pattern of emphysema. CONCLUSION: The most important selection criteria for lung volume reduction surgery is the presence of a bilateral upper lobe heterogeneous pattern of emphysema on chest computed tomography and lung perfusion scan. After patients have been selected on the basis of a heterogeneous pattern of emphysema, clinical factors and physiology are not associated with clinical outcome well enough to further refine patient selection criteria. These results do not support the arbitrary patient selection criteria for lung volume reduction surgery reported in the literature.


Subject(s)
Patient Selection , Pneumonectomy , Pulmonary Emphysema/surgery , Age Factors , Aged , Contraindications , Female , Humans , Lung/diagnostic imaging , Male , Prednisone/therapeutic use , Pulmonary Emphysema/diagnosis , Pulmonary Emphysema/physiopathology , Radionuclide Imaging , Respiratory Function Tests , Tomography, X-Ray Computed , Treatment Outcome
9.
Cancer ; 73(4): 1163-70, 1994 Feb 15.
Article in English | MEDLINE | ID: mdl-8313318

ABSTRACT

BACKGROUND: Bronchioloalveolar lung carcinoma (BAC) is a unique type of lung cancer with distinguishing pathologic, biologic, epidemiologic, demographic, and perhaps etiologic features. METHODS: The authors investigated and analyzed all of the cases of pathologically confirmed BAC seen at our institution in the hope of discovering new or confirming known features of this disease. RESULTS: When cases of BAC expressed as a percentage of total lung cancers were analyzed in successive 5-year periods from 1955 to 1990, BAC rose from less than 5% to 24.0% (P < 0.001). Much of the increase in BAC occurred in women, as evidenced by a male-to-female ratio that wavered around unity. The mean age of BAC adenocarcinoma patients was 59.2 +/- 11.5 years, compared to 64.1 +/- 13.5 years for non-BAC adenocarcinoma (P < 0.05). BAC also contrasted with other forms of lung cancer by exhibiting a relatively high incidence of multifocality (25% versus 5%) (P < 0.001). There was an association between histologic subtype of BAC and pattern of pulmonic involvement. The mucinous subtype was more strongly associated with diffuse pulmonic involvement, and the sclerotic subtype was more strongly associated with multifocal involvement (P < 0.001). Furthermore, BAC cases exhibited a 20% incidence of dedifferentiation into patterns of poorly differentiated adenocarcinoma, a feature that was more associated with the mucinous and sclerotic subtypes (P < 0.05). CONCLUSIONS: The emergence of BAC as a prominent type of lung cancer should stimulate new basic laboratory and case-control studies to elucidate further the natural history and etiology of this unique disease.


Subject(s)
Adenocarcinoma, Bronchiolo-Alveolar/epidemiology , Adenocarcinoma, Bronchiolo-Alveolar/pathology , Lung Neoplasms/epidemiology , Lung Neoplasms/pathology , Adenocarcinoma, Bronchiolo-Alveolar/physiopathology , Aged , Female , Humans , Incidence , Lung Neoplasms/physiopathology , Male , Middle Aged
10.
Int J Cancer ; 54(1): 44-8, 1993 Apr 22.
Article in English | MEDLINE | ID: mdl-8386708

ABSTRACT

The importance of cigarette smoking as a risk factor for specific histologic types of lung cancer in men and women has been examined in a case-control analysis of data from the Cancer Surveillance Program of Orange County, a population-based registry. Smoking habits were abstracted from medical records for 1153 men and 833 women diagnosed with primary lung cancer in 1984-1986 and 1851 men and 1656 women aged 30 or older diagnosed with cancers not associated with smoking. Ninety-six percent of men and 89% of women with lung cancer were current or former cigarette smokers, as compared with 55% of men and 34% of women with other cancers. The age and ethnicity-adjusted odds ratios (OR) for ever-smoking were 19.7 for men and 15.0 for women. Men and women who smoked 2 or more packs per day experienced nearly equal risks. Comparison of the most common cell types showed that women smokers had equal or lower ORs for squamous-cell carcinoma and adenocarcinoma, but higher OR for small-cell carcinoma, as compared with men smokers. While the smoking-associated OR were equal for small-cell and squamous-cell carcinomas in men, the OR for women were significantly higher for small-cell carcinoma than for squamous-cell carcinoma.


Subject(s)
Carcinoma/epidemiology , Lung Neoplasms/epidemiology , Smoking/adverse effects , Adenocarcinoma/epidemiology , Carcinoma, Small Cell/epidemiology , Carcinoma, Squamous Cell/epidemiology , Female , Humans , Male , Odds Ratio , Plants, Toxic , Risk Factors , Sex Factors , Nicotiana
11.
Cancer Res ; 51(18): 4893-7, 1991 Sep 15.
Article in English | MEDLINE | ID: mdl-1654203

ABSTRACT

The importance of smoking and other factors for lung cancer in women was investigated in a case-control study of women who had previously received a multiphasic health checkup at Northern California Kaiser Hospitals. Smoking and medical histories for 217 cases and matched controls were obtained from the multiphasic questionnaire. Odds ratios (ORs) and confidence intervals (CIs) associated with cigarette smoking were 35.1 (95% CI 4.8-256) for squamous and small cell and large cell carcinomas combined and 2.5 (95% CI 1.3-5.1) for adenocarcinoma. After adjusting for smoking, risk was increased in women with a family history of lung cancer (OR 1.9, 95% CI 0.7-5.6) and family history of any cancer (OR 1.8, 95% CI 1.0-3.2). A significant interaction existed between smoking and family history. Women with a history of bronchitis, pneumonia, or emphysema were at increased risk, whereas women with a history of asthma or hay fever experienced a significantly lower risk for lung cancer.


Subject(s)
Adenocarcinoma/epidemiology , Carcinoma, Non-Small-Cell Lung/epidemiology , Carcinoma, Small Cell/epidemiology , Carcinoma, Squamous Cell/epidemiology , Lung Neoplasms/epidemiology , Women's Health , Adenocarcinoma/genetics , Carcinoma, Non-Small-Cell Lung/genetics , Carcinoma, Small Cell/genetics , Carcinoma, Squamous Cell/genetics , Case-Control Studies , Family Health , Female , Humans , Lung Neoplasms/genetics , Male , Middle Aged , Respiratory Tract Diseases/epidemiology , Risk Factors , Smoking/adverse effects
12.
Cancer Res ; 48(22): 6580-3, 1988 Nov 15.
Article in English | MEDLINE | ID: mdl-2846154

ABSTRACT

Using data from a population-based registry, the Cancer Surveillance Program of Orange County, we examined patterns in lung cancer incidence by histological type for 1984 in Orange County, CA. Age-adjusted incidence rates per 100,000 population are 66.4 for men and 34.1 for women. Compared to 1983 rates for whites from all SEER areas combined, Orange County incidence rates are lower for men but equal for women. Squamous cell carcinoma incidence shows a strong male predominance [male/female 3.4; 95% confidence interval = (2.6, 4.4)], whereas the male/female incidence ratios for adenocarcinoma [male/female 1.4; 95% confidence interval = (1.1, 1.8)] and small cell carcinoma [male/female = 1.8; 95% confidence interval = 1.3, 2.4)] are closer to unity. Smoking habits were abstracted from medical records for 79% of cases. Only 8% of lung cancer cases (5% of men and 12% of women) with known smoking habits are nonsmokers. Adenocarcinoma is the most common cell type among women smokers and nonsmokers, while squamous cell carcinoma predominates in both male smokers and nonsmokers. Cases who smoked were younger at diagnosis than nonsmokers (P less than 0.001) for each cell type. Despite a greater proportion of nonsmokers, cases with adenocarcinoma were younger at diagnosis compared to small cell carcinoma (P less than 0.01) and squamous cell carcinoma (P less than 0.05). The observed patterns of incidence rates by histological type are not entirely explained by current knowledge of the relationship between smoking and cell type.


Subject(s)
Lung Neoplasms/epidemiology , Registries , Adenoma/epidemiology , Adolescent , Adult , Age Factors , Aged , Analysis of Variance , California , Carcinoma, Small Cell/epidemiology , Child , Child, Preschool , Female , Humans , Infant , Infant, Newborn , Male , Middle Aged , Sex Factors , Smoking
SELECTION OF CITATIONS
SEARCH DETAIL
...